Author Sachse-Seeboth, Cordula

1 to 4 of 4 Items
  • 2009 | Conference Abstract
    ​ ​Interindividual Variation in Pharmacokinetics of Delta-9-Tetrahydrocannabinol and Genetic Polymorphisms in Cyp2c9​
    Brockmoeller, J.; Sachse-Seeboth, C.; Pfeil, J.; Sehrt, D.; Meineke, I.; Tzvetkov, M. V. & Bruns, E. et al.​ (2009)
    Basic & Clinical Pharmacology & Toxicology, 104(6) 
    Malden​: Wiley-blackwell Publishing, Inc.
    ​Details  WoS 
  • 2015 | Journal Article
    ​ ​Heritability of Metoprolol and Torsemide Pharmacokinetics​
    Matthaei, J. ; Brockmöller, J. ; Tzvetkov, M. V. ; Sehrt, D.; Sachse-Seeboth, C.; Hjelmborg, J. B. & Möller, S. et al.​ (2015) 
    Clinical Pharmacology & Therapeutics, 98(6) pp. 611​-621​.​ DOI: https://doi.org/10.1002/cpt.258 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article | 
    ​ ​Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters​
    Matthaei, J.; Tzvetkov, M. V.; Gal, V.; Sachse-Seeboth, C.; Sehrt, D.; Hjelmborg, J. B. & Hofmann, U. et al.​ (2016) 
    Genome Medicine, 8 art. 119​.​ DOI: https://doi.org/10.1186/s13073-016-0372-2 
    ​Details  DOI  PMID  PMC  WoS 
  • 2020 | Journal Article | 
    ​ ​Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans​
    Matthaei, J. ; Bonat, W. H.; Kerb, R.; Tzvetkov, M. V. ; Strube, J.; Brunke, S. & Sachse-Seeboth, C. et al.​ (2020) 
    Frontiers in Genetics, 11.​ DOI: https://doi.org/10.3389/fgene.2020.00944 
    ​Details  DOI 

Researcher

Göttingen All

Sort

issue date

ASC DESC

Items per Page

10 20 50 100